Loading stock data…
FIGS
$11.66+0.08 (+0.69%)
Market ClosedLast close Jun 9
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
FIGS, Inc. in the Consumer Cyclical sector is trading at $11.66. Wall Street consensus targets $17.62 (8 analysts), implying a +51.2% move over the next 12 months. The stock is currently 33% below its 52-week high of $17.48, remaining 5.0% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +51.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
AMZNTSLAHD
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$11.66
Potential Downside
0%
Whystock Fair Value$11.66
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.44%
Volume
Today's trading volume
2.20M
Recent News
FIGS vs. Gildan Activewear: Which Consumer Stock Is a Better Buy in 2026?
One company powers healthcare apparel with direct sales and rapid growth, while the other scales global basics with steady cash flow and lower valuations.
3 Small-Cap Stocks That Concern Us
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Brunswick, Figs, Marriott Vacations, WeightWatchers, and PVH Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after easing pressure in the bond market and a pullback in oil prices boosted investor sentiment for consumer-facing companies.
FIGS Q1 Strength Tests Market Sentiment As Growth Outlook Rises
FIGS (NYSE:FIGS) reported strong Q1 2026 results, with revenue and profitability exceeding internal expectations. Performance was supported by new product releases, customer growth, and expanding international operations. The company achieved this against a backdrop of tariffs, freight costs, and other macro and operational pressures. For investors watching NYSE:FIGS, the latest quarter lands after a pullback of 29.0% over the past month, alongside a 151.8% gain over the past year. The...
FIGS Q1 Deep Dive: Strong Revenue Growth Overshadowed by Market Concerns on Sustainability
Healthcare apparel company Figs (NYSE:FIGS) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 28% year on year to $159.9 million. Its non-GAAP profit of $0.03 per share was $0.01 above analysts’ consensus estimates.